,,iii  #aag? ,,congress  #a/ ,session   
,s4 ,,res4 #acg  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,m>* #be1 #bjba,mr4   
,br[n 7= himself & ,mr4 ,sullivan7      
submitt$ ! foll[+ resolution2 :i* 0     
ref]r$ to ! ,committee on ,=eign        
,relations  ,,resolution  ,support+ !   
goals ( ,_w ,tub]culosis ,day to raise  
aw>5ess ab\t tub]culosis4  ,:]eas1 9    
#bjai1 ne>ly  ( ! global population 0   
infect$ ) ! tub]culosis bact]ium 7ref]r$
 to 9 ?is preamble z ,,tb72 ,:]eas ! ,_w
 ,heal? ,organization 7ref]r$ to 9 ?is  
preamble z ! ,,:o7 e/imates t           
#aj1jjj1jjj p develop$ ,,tb 9 #bjai1    
#h4b p]c5t ( :om 7 also infect$ ) !     
human immunodefici5cy virus 7ref]r$ to 9
 ?is preamble z ,,hiv72 ,:]eas1 9 #bjai1
 ,,tb kill$ an e/imat$ #a1djh1jjj p1    
caus+ m dea?s worldwide ?an any o!r s+le
 infecti\s ag5t2 ,:]eas1 globally 9     
#bjai1 an e/imat$ #a1bjj1jjj *ildr5     
develop$ ,,tb1 & 9 #bjag1 #bcj1jjj      
*ildr5 di$ ( ,,tb2 ,:]eas #b_/c ( new   
,,tb infections 9 #bjai occurr$ 9 #h    

c\ntries3 ,india1 ,indonesia1 ,*9a1 !   
,philipp9es1 ,paki/an1 ,nig]ia1         
,banglade%1 & ,s\? ,africa2 ,:]eas ,,tb 
is a lead+ kill] ( p infect$ ) ,,hiv1 & 
#bjh1jjj p ) ,,hiv di$ ( ,,tb 9 #bjai2  
,:]eas vuln]able populations also at    
high risk = develop+ ,,tb include       
individuals :o are pregnant & newborns2 
,:]eas1 9 #bjah1 ,,tb 0 "o ( ! #f lead+ 
causes ( dea? among adult wom5 betwe5 ! 
ages ( #ae & #di 9 l[-income c\ntries2  
,:]eas1 9 "s sett+s1 wom5 ) ,,tb c face 
/igma1 discrim9ation1 & o/racization by 
_! families & communities2 ,:]eas !     
global ,,tb epidemic & ! spread (       
drug-resi/ant ,,tb pres5t a p]si/5t     
public heal? ?reat to ! ,unit$ ,/ates   
because ! disease does n recognize      
bord]s2 ,:]eas antibiotic-resi/ant      
pa?og5s are a gr[+ problem worldwide1 & 
drug-resi/ant ,,tb c occur :5 ! drugs   
us$ to treat ,,tb are mismanag$ or n    
made consi/5tly accessible2 ,:]eas      
/udies h demon/rat$ direct              
p]son-to-p]son transmission (           

drug-resi/ant ,,tb2 ,:]eas multi-drug   
resi/ant ,,tb 7ref]r$ to 9 ?is preamble 
z 8,,mdr-,,tb07 is caus$ by bact]ia )   
resi/ance to rifamp9 & isoniazid1 ! #b  
mo/ pot5t treatm5ts = ,,tb infection2   
,:]eas1 9 #bjai1 accord+ to ! #bjbj ,,:o
 ,global ,tub]culosis ,report1 an       
e/imat$ #c4c p]c5t ( all new ,,tb cases 
& #ah p]c5t ( previ\sly treat$ cases 7  
,,mdr-,,tb or rifamp9-resi/ant ,,tb2    
,:]eas1 9 #bjai1 an e/imat$ #dfe1jjj p  
ar\nd ! _w develop$ ,,mdr-,,tb or       
rifamp9-resi/ant ,,tb1 yet only         
approximately #ch p]c5t ( ^? individuals
 7 id5tifi$ & treat$2 ,:]eas ext5sively 
drug-resi/ant ,,tb 7ref]r$ to 9 ?is     
preamble z 8,,xdr-,,tb07 is a r>e type (
 ,,tb t is resi/ant to ne>ly all        
m$ic9es1 & !re=e c be v difficult &     
exp5sive to treat1 especially among     
pati5ts ) ,,hiv2 ,:]eas1 9 #bjai1 e ,,:o
 region report$ ,,xdr-,,tb cases2       
,:]eas1 9 #bjai1 ! ,c5t]s = ,disease    
,control & ,prev5tion 7ref]r$ to 9 ?is  
preamble z ,,cdc7 e/imat$ t ! av]age co/

 ( treat+ a s+le pati5t ) ,,mdr-,,tb 9 !
 ,unit$ ,/ates 0 #agh1jjj1 & ! av]age   
co/ ( treat+ a pati5t ) ,,xdr-,,tb 0 ev5
 high] at #eec1jjj1 comp>$ ) #bj1jjj to 
treat a pati5t ) drug-susceptible ,,tb2 
,:]eas1 betwe5 #bjje & #bjjg1 accord+ to
 an analysis by ,,cdc1 ,,mdr-,,tb &     
,,xdr-,,tb cases 9 ! ,unit$ ,/ates      
collectively co/ ! heal? c>e sy/em an   
e/imat$ #ec1jjj1jjj2 ,:]eas ,,cdc       
e/imates t co/s result+ f all =ms ( ,,tb
 9 ! ,unit$ ,/ates total$ m ?an         
#fjh1jjj1jjj 9 #bjai2 ,:]eas1 9 a #bjjj 
report1 ! ,in/itute ( ,m$ic9e f\nd t a  
decrease 9 ,,tb control fund+ & ! spread
 ( ,,hiv & acquir$ immune defici5cy     
syndrome 7commonly ref]r$ to z ,,aids7  
caus$ a resurg5ce ( ,,tb 9 ! late #aihjs
 & e>ly #aiijs2 ,:]eas a total ( #h1iaf 
,,tb cases 7 report$ 9 ! ,unit$ ,/ates 9
 #bjai1 repres5t+ all #ej ,/ates & !    
,di/rict ( ,columbia1 & up to           
#ac1jjj1jjj p 9 ! ,unit$ ,/ates are     
e/imat$ to be liv+ ) lat5t ,,tb         
infection2 ,:]eas #ge p]c5t ( ,/ates h  

report$ an increase 9 ! proportion (    
complex cases ( ,,tb 9 rec5t ye>s due to
 factors su* z homelessness1 ,,hiv      
infection1 drug resi/ance1 sub/ance     
abuse1 refugee /atus1 & o!r factors2    
,:]eas ! rate ( ,,tb disease 9 ,african 
,am]icans is #h times high] ?an ! rate (
 disease 9 ,:ite1 non-,hispanic         
,am]icans1 & significant disp>ities exi/
 among o!r m9orities 9 ! ,unit$ ,/ates1 
includ+ ,asian ,am]icans1 ,hispanic     
,am]icans1 & ,native ,am]icans & ,alaska
 ,natives1 ) approximately #hh p]c5t (  
all report$ ,,tb cases 9 ! ,unit$ ,/ates
 9 #bjai occurr+ 9 racial or e?nic      
m9orities2 ,:]eas smok+-- 7#a7 greatly  
increases ! risks ( contract+ ,,tb &    
infection recurr5ce2 &  7#b7 impairs    
!rapeutic efficacy2 ,:]eas diabetes is a
 major risk factor = ,,tb1 & p )        
diabetes are m likely to develop &      
succumb to ,,tb2 ,:]eas b$aquil9e is an 
antibiotic t boo/s an ,,mdr-,,tb        
pati5t's *ance ( survival f             
approximately #ej p]c5t to z mu* z #hj  

p]c5t1 & ?r\gh a public-private         
p>tn]%ip1 ! ,unit$ ,/ates ,ag5cy =      
,int]national ,developm5t 7ref]r$ to 9  
?is preamble z ,,usaid7 provid$         
approximately #aje1jjj treatm5ts 9 #aaj 
eligible c\ntries f #bjae ?r\gh #bjai2  
,:]eas ,bacillus ,calmette-,gu]91 a ,,tb
 vacc9e t is kn[n z ,,bcg1 provides "s  
protection to infants & "y *ildr5 aga9/ 
s]i\s =ms ( *ildhood ,,tb b has _h      
little epidemiologic impact on controll+
 ,,tb worldwide2 ,:]eas !re is a        
critical ne$ = new drugs1 diagno/ics1 & 
vacc9es = controll+ ! global ,,tb       
epidemic2 ,:]eas1 9 ,septemb] #bjah1 !  
,unit$ ,nations held ! fir/ high-level  
meet+ on ,,tb 9 :i* #abj c\ntries1      
includ+ ! ,unit$ ,/ates1 sign$ a        
political decl>ation committ+ to        
accel]at+ ! ,,tb response1 includ+ by   
increas+ fund+ = ,,tb control programs &
 rese>* & developm5t ef=ts1 ) ! goal (  
rea*+ all affect$ p ) ,,tb prev5tion &  
c>e2 ,:]eas ! enactm5t ( ! ,tom ,lantos 
& ,h5ry ,j4 ,hyde ,unit$ ,/ates ,global 

,lead]%ip ,aga9/ ,,hiv_/,,aids1         
,tub]culosis1 & ,mal>ia ,reau?orization 
,act ( #bjjh 7,public ,law #aaj-bic2    
#abb ,/at4 #biah71 & ! ,compreh5sive    
,tub]culosis ,elim9ation ,act ( #bjjh   
7,public ,law #aaj-cib2 #abb ,/at4      
#daie7 l$ to a hi/oric ,unit$ ,/ates    
commitm5t to support ! global           
eradication ( ,,tb1 includ+ a commitm5t 
to treat #d1ejj1jjj ,,tb pati5ts &      
#ij1jjj ,,mdr-,,tb pati5ts betwe5 #bjji 
& #bjac & to provide additional treatm5t
 ?r\gh coord9at$ multilat]al ef=ts2     
,:]eas ,,usaid-- 7#a7 provides te*nical 
assi/ance to #ee c\ntries & implem5ts   
bilat]al programs 9 #bc high-burd5 ,,tb 
c\ntries t-- 7,a7 build capacity2 &     
7,b7 support ! adoption ( /ate-(-!-art  
,,tb-relat$ te*nologies2  7#b7 supports 
! developm5t ( new diagno/ic & treatm5t 
tools2 &  7#c7 supports rese>* to       
develop new vacc9es & o!r new me?ods to 
combat ,,tb2 ,:]eas1 9 #bjah1 ,,usaid   
laun*$-- 7#a7 a new bus9ess model       
entitl$ ,global ,accel]ator to ,end     

,tub]culosis to accel]ate progress &    
build capacity ) respect to ,,tb        
prev5tion & treatm5t2 &  7#b7 a new     
me*anism to directly support local      
organizations 9 priority c\ntries2      
,:]eas ,,tb incid5ce 9 ! c\ntries t     
receive bilat]al ,,tb fund+ f ! ,unit$  
,/ates ?r\gh ,,usaid has decreas$ by m  
?an #bi p]c5t s9ce #bjjj2 ,:]eas1       
accord+ to ! ,cop5hag5 ,cons5sus ,c5t]1 
,,tb prev5tion programs return #ef = ea*
 doll> inve/$1 :i* is "o ( ! highe/     
returns on inve/m5t ( any heal?         
int]v5tion2 ,:]eas ,,cdc1 9 p>tn]%ip )  
o!r entities ( ! ,unit$ ,/ates &        
individual ,/ates & t]ritories-- 7#a7   
directs ! national ,,tb elim9ation      
program2  7#b7 coord9ates ,,tb          
surveillance1 te*nical assi/ance1 &     
prev5tion activities2 &  7#c7 helps to  
support ! developm5t ( new diagno/ic1   
treatm5t1 & prev5tion tools to combat   
,,tb2 ,:]eas ! ,national ,in/itutes (   
,heal?1 ?r\gh its _m in/itutes & c5t]s1 
plays ! lead+ role 9 basic & cl9ical    

rese>* on ! id5tification1 treatm5t1 &  
prev5tion ( ,,tb2 ,:]eas ! ,global ,fund
 to ,fight ,,aids1 ,tub]culosis &       
,mal>ia 7ref]r$ to 9 ?is preamble z !   
,global ,fund71 to :i* ! ,unit$ ,/ates  
is a top f9ancial donor1 provides m ?an 
#gc p]c5t ( all int]national f9anc+ =   
,,tb programs2 ,:]eas1 9 #bjai1 ,global 
,fund-support$ programs detect$ & treat$
 m ?an #e1gjj1jjj cases ( ,,tb2 ,:]eas !
 coronavirus disease #bjai 7,,covid-#ai7
 p&emic & mitigation ef=ts put 9 place z
 a result ( ! p&emic h tak5 a deva/at+  
toll on c\ntries ) ! highe/ burd5 ( ,,tb
 disease & on ! global ,,tb response1   
?reat5+ to rev]se up to #h ye>s (       
progress fight+ ! disease2 ,:]eas1 9    
#bjbj1 9 ! #bc high-burd5 ,,tb c\ntries 
9 :i* ,,usaid implem5ts bilat]al        
programs1 #a1jjj1jjj few] p ) ,,tb _h   
access to diagnosis & treatm5t1 a #bc   
p]c5t decl9e f #bjai2 ,:]eas1 betwe5    
#bjbj & #bjbe1 global projections       
e/imate t ! impact ( ! ,,covid-#ai      
p&emic w lead to an additional          

#f1cjj1jjj cases ( ,,tb & an additional 
#a1djj1jjj ,,tb dea?s2 & ,:]eas ,m>*    
#bd1 #bjba1 is ,_w ,tub]culosis ,day1 a 
day t commemorates ! date 9 #ahhb on :i*
 ,dr4 ,rob]t ,ko* ann\nc$ 8 discov]y (  
,mycobact]ium tub]culosis1 ! bact]ium t 
causes ,,tb3 ,n[1 !re=e1 be x ,t !      
,s5ate-- 7#a7 supports ! goals ( ,_w    
,tub]culosis ,day to raise aw>5ess ab\t 
tub]culosis2  7#b7 comm5ds ! progress ( 
tub]culosis elim9ation ef=ts by entities
 t include ! ,unit$ ,/ates ,ag5cy =     
,int]national ,developm5t1 ! ,c5t]s =   
,disease ,control & ,prev5tion1 !       
,national ,in/itutes ( ,heal?1 ! ,_w    
,heal? ,organization1 & ! ,global ,fund 
to ,fight ,,aids1 ,tub]culosis &        
,mal>ia2 &  7#c7 reaffirms ! commitm5t  
to /r5g!n ! lead]%ip role ( ! ,unit$    
,/ates 91 & ! effectiv5ess ( ! global   
response to1 ! fight to end !           
tub]culosis epidemic4